
Guidelines Office Project Coordinator European Association of Urology @uroweb @ProstatePioneer
Eindhoven, the Netherlands
Joined December 2019
- Tweets70
- Following67
- Followers133
- Likes138
All driven by our fantastic chair @MariaJRibal and Guidelines Board @bjartell @MoniqueRoobol @NDowJames @philcornford @DrSteveCanfield Thomas Knoll & Alberto Briganti #eauguidelines
Do you think a rockstar ⭐️⭐️⭐️⭐️could be as successful as we are???? 😍😍😍😍 #eauguidelines #EAU22 @EmmaJSmith9 @JulieADarraugh @Carla99008272 @Karin_MJ_Plass @silvialina21 @NDowJames @Uroweb THANK YOU ALL WITHOUT YOU THIS IS NOT POSSIBLE..!!
📢 #eauguidelines ready and waiting at booth D60 at the exhibition hall of #EAU22. The Guidelines Office are looking forward to seeing you there! @NDowJames @MariaJRibal @Carla99008272 @JulieADarraugh @Uroweb
Emma Jane Smith retweeted
Today is the official launch of OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence)!
🔍 36 partners
🔍 3 countries
🔍 budget: € 21.3 million
Press release out now: https://nitter.cf/t.co/3iTOVcDBLr.
Fantastic kick-off meeting lots of committed partners ready to drive @OPTIMA_oncology to success! @Uroweb @NDowJames @JarkaBloemberg
Emma Jane Smith retweeted
Emma Jane Smith retweeted
Discussing the challenges facing patients with prostate cancer with @Uroweb.
With the support of all stakeholders, we can ensure that #EUCancerPlan can give 🇪🇺 cancer patients and their families hope for a better future.
Emma Jane Smith retweeted
#followermilestone! Proud to say that #ProstatePIONEER just gained its 1,000th follower. Thank you for helping us to raise awareness for #ProstateCancer. prostate-pioneer.eu/ @MariaJRibal @alexhabs @NDowJames
#openscience at it's best join the @ProstatePioneer and partners tonight for the first results from their global #ProstateCancer study @uroweb #eauguidelines
All week Pioneer @IMI_EHDEN @OHDSI have been running a global 24/7 #ProstateCancer study. Join us live at 19.00 CET to celebrate this great achievement in #openscience & get new insights into the outcomes of PCa patients undergoing watchful waiting: https://nitter.cf/t.co/gphEnQma34
New insights coming!
The 5th and final day of the #ProstateCancer studyathon is off to a flying start. Cohort population numbers are in and growing as the analytics from a growing number of datasets is reported. Making for some very "Shiny Appy" team members! @OHDSI @IMI_JU @IMI_EHDEN
Emma Jane Smith retweeted
1 plus of virtual working the studyathon is active 24/7 spanning multiple time zones. Day 3 in Europe is drawing to a close & what a day with 2 inspiring patient stories & the first data analysis. Overall feeling is one of knowledge gained! Handing over for the nightshift
Emma Jane Smith retweeted
Snapshot of day 1 PIONEER @IMI_EHDEN @OHDSI #ProstateCancer studyathon 200 participants form 20 plus countries, working groups up and running clinical characterisation, phenotyping, prediction, data sources and more! Glad to see the overall outlook is curiosity @IMI_JU @EFPIA
Looking forward to also hearing from @GaryHooker16 @KenMastris and Erik Briers as the week progresses. With patients for patients @cancereu @ecancer @EauPatient
.@ProstatePioneer @IMI_EHDEN @OHDSI studyathon kicks off with over 200 registered participants from across the globe. Patient representative @SimeonRGreene shared his personal #prostatecancer experience reminding us that behind that data is patients and their families
Emma Jane Smith retweeted
#ProstatePIONEER, @IMI_EHDEN and @OHDSI will host a virtual studyathon 8-12 March 2021. Attendees will join forces to uncover the natural history of #prostatecancer in data from millions of patient across the globe. Find out more at: https://nitter.cf/t.co/2Idpt96v6F @BD4BO @IMI_JU @EFPIA
Emma Jane Smith retweeted
📢News: #DataSharing Agreement signed with Prof. Gacci @AOUCareggi. 3 data sets of >5000 men with biopsy-verified treatment-naïve #prostatecancer who underwent radical prostatectomy shared to the PIONEER #BigData platform. More info: https://nitter.cf/t.co/QKfTG3XHve
@BD4BO @IMI_JU
Day 2 of the virtual #ProstatePioneer General Assembly we are ready to go! On todays agenda:
electronic health records pilot results; prioritised research question progress and the upcoming PIONEER study-a-thon @IMI_JU @EFPIA @BD4BO
Emma Jane Smith retweeted
In need of some interesting listening for the evening commute or that lunchtime walk? Why not check out @Sevans_axelsson discussing #BigData #ProstateCancer with @ClareDelmar on the @TheFocalTC podcast series to mark #InternationalMensDay: https://nitter.cf/t.co/VE7KgSmkE2
Emma Jane Smith retweeted
Next in our #Movember2020 series is Prof. James N’Dow - the Coordinator of the PIONEER project. He is the Chairman of the EAU Guidelines Office and Professor of Urology at Aberdeen University. #ProstateCancer @NDowJames @aberdeenuni @uroweb
Emma Jane Smith retweeted
#Movember2020 series 6/10: Prof. Maria J. Ribal leads the work package communication & dissemination. WP7 runs parallel to the other WPs during the entire lifecycle of PIONEER & focuses on making the project’s aims, objectives & results publicly available. @MariaJRibal @uroweb
Emma Jane Smith retweeted
At #EPAD20, I'll propose an evidence-based algorithm as a potential way forward for risk-stratified #EarlyDetection of #ProstateCancer. The argument against PSA screening is that it would expose men to overdiagnosis and overtreatment. This algorithm will prevent exactly that.
"If the EU is serious about decreasing the cancer mortality in its member states, it should include clinical guidelines on #EarlyDetection and diagnosis of #ProstateCancer in the #EUCancerPlan.” -@heinvanpoppel about #EPAD20 and its aim.
Full interview👉uroweb.org/epad20-a-landmark…
Emma Jane Smith retweeted
#eauguidelines has been a pioneer strategy to disseminate GL’s into #socialmedia. Check this SR from our group @NikitaB0709 @GGiannarini @DrCzarniecki @LoebStacy @onco_uroloog @BenjaminPradere @fraesperto @JulieADarraugh @JarkaBloemberg @marcvangurp sciencedirect.com/science/ar…































